Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Net Debt / (EBITDA-CAPEX)

Gilead Sciences Inc Net Debt / (EBITDA-CAPEX) Chart (GILD)

Gilead Sciences Inc annual/quarterly Net Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Gilead Sciences Inc Net Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $0m a 160.45% increase of 0m year over year
  • Gilead Sciences Inc Net Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $0m a 136.31% increase of 1m year over year
  • Gilead Sciences Inc Annual Net Debt / (EBITDA-CAPEX) for 2019 was $0m a -267.63% increase of 0m from 2018
  • Gilead Sciences Inc Annual Net Debt / (EBITDA-CAPEX) for 2018 was $-1m a 59.91% decrease of 0m from 2017
  • Gilead Sciences Inc Annual Net Debt / (EBITDA-CAPEX) for 2017 was $0m a -53.56% increase of 0m from 2016
Other Ratios Metrics:
  • Gilead Sciences Inc Total Debt / Capital for the quarter ending December 12, 2018 was $59m a 1.63% increase of 1m year over year
  • Gilead Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $6,612m a -11.19% decrease of -740m year over year
  • Gilead Sciences Inc Total Debt / Equity for the quarter ending December 12, 2018 was $146m a 3.93% increase of 6m year over year
View Chart On Koyfin

Quarterly GILD Net Debt / (EBITDA-CAPEX) Data

09/2020$0m
06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$-1m
09/2018$0m
06/2018$0m

Annual GILD Net Debt / (EBITDA-CAPEX) Data

2019$0m
2018$-1m
2017$0m
2016$0m
2015$0m
2014$0m
2013$1m
2012$1m
2011$-1m
2010$0m